Abstract:Adiponectin receptor agonists have recently been reported to protect against glomerular inflammation and injury during obesity. Nevertheless, the molecular mechanism underlying their protective action against obesity-related glomerulopathy (ORG) remains poorly understood. Given the implication of ceramide signaling pathway in the pathogenesis of ORG, the present study tested whether adiponectin receptor agonists target lysosomal acid ceramidase (AC) to inhibit NLRP3 inflammasome activation and glomerular injury during obesity. Confocal microscopy showed that NLRP3 inflammasome activation induced by visfatin, a pro-inflammatory adipokine, in murine podocytes was remarkably attenuated by adiponectin. Also, it was found that adiponectin significantly inhibited visfatin-induced formation of multivesicular bodies (MVBs) containing IL-1β in podocytes. Such inhibitory effect of adiponectin was abolished by AC inhibitors (carmofur and ARN14974) but mimicked by genistein (AC inducer) or MCC950 (NLRP3 inflammasome inhibitor). By nanoparticle tracking analysis, we measured exosomes released from podocytes in different groups, which have been reported to mediate the secretion of NLRP3 inflammasome products to extracellular space to activate inflammatory response. Visfatin-induced elevation of exosome release from podocytes was remarkably suppressed by adiponectin. This action of adiponectin was blocked by AC inhibitors but mimicked by genistein. In vivo, we showed that high-fat diet-induced T cell infiltration in glomeruli was exaggerated by podocyte-specific Smpd1 gene (gene code of acid sphingomyelinase) overexpression in Smpd1trg/Podocre mice compared to WT/WT mice. However, intraperitoneal injection of AdipoRon, a synthetic adiponectin receptor agonist, significantly decreased obesity-induced glomerular inflammatory response in both WT/WT and Smpd1trg/Podocre mice. Such anti-inflammatory effect of AdipoRon was prevented by co-treatment with carmofur. Moreover, podocyte-specific Smpd1 gene overexpression amplified HFD-induced podocyte injury, proteinuria, and glomerular sclerosis in Smpd1trg/Podocre mice compared to control littermates. These pathological changes were prevented by AdipoRon, and the effect of AdipoRon was reversed by carmofur. Taken together, our findings suggest that activation of AC signaling pathway mediates the protective action of adiponectin receptor agonists against glomerular inflammation and injury in ORG. This study was supported by NIH grants DK054927 and DK120491. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Inhibition of pannexin-1 channel activity by adiponectin in podocytes: Role of acid ceramidase activation

Calcineurin Inhibitors Ameliorate PAN‐induced Podocyte Injury Through the NFAT–Angptl4 Pathway

Pannexin 1, a Large-Pore Membrane Channel, Contributes to Hypotonicity-Induced ATP Release in Schwann Cells.

Pannexin1 channels-a potential therapeutic target in inflammation

Inhibition of Schwann Cell Pannexin 1 Attenuates Neuropathic Pain Through the Suppression of Inflammatory Responses

Acid Ceramidase as a Novel Target for Adiponectin Receptor Agonist to Abrogate NLRP3 Inflammasome Activation and Glomerular Injury during Obesity

Camp Signaling Prevents Podocyte Apoptosis Via Activation of Protein Kinase A and Mitochondrial Fusion

Poricoic acid a ameliorates high glucose-induced podocyte injury by regulating the AMPKα/FUNDC1 pathway

The Attenuation of Diabetic Nephropathy by Annexin A1 via Regulation of Lipid Metabolism Through the AMPK/PPARα/CPT1b Pathway.

ATP-release pannexin channels are gated by lysophospholipids

The Attenuation of Diabetic Nephropathy by Annexin A1 via Regulation of Lipid Metabolism Through the AMPK/PPAR/CPT1b Pathway

Role of C/EBP-α in Adriamycin-induced podocyte injury

Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway

A2A Receptor-induced Overexpression of Pannexin-1 Hemichannels Indirectly Mediates Adenosine Fibrogenic Actions in Subcutaneous Human Fibroblasts by Favoring ATP Release

Abstract P2028: A Role For Pannexin 1 In Heart Failure Induced By Acute And Chronic Isoproterenol Administration

A Critical Role for Pannexin 1 in Heart Failure Induced by Acute and Chronic Isoproterenol Administration

Deacetylation as a receptor-regulated direct activation switch for pannexin channels

Adiponectin Inhibits TNF-α-Activated PAI-1 Expression Via the Camp-Pka-ampk-nf-κb Axis in Human Umbilical Vein Endothelial Cells

Abstract 109: Adiponectin Inhibits TNF-a-Induced Vascular Inflammatory Response via Caveolin-Mediated Ceramidase Recruitment and Activation

Adiponectin inhibits tumor necrosis factor-α-induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation

Role Of C/Ebp-Alpha In Adriamycin-Induced Podocyte Injury